Celltrion Posts Record-High Q2 Earnings with 235% Surge in Operating Profit 송영두 2025.07.21 오전 10:03 Celltrion biosimilars expand dominance in Japan’s oncology market 임정요 2025.06.13 오전 10:11 Celltrion Unfazed by U.S. Price Cuts, Tariffs Zymfentra Drag Tied to Insurance 송영두 2025.05.15 오후 03:23 Seo Jung-jin Reappointed, Celltrion Confident in 5 Trillion Sales Goal 송영두 2025.03.25 오후 05:08 Remsima SC Captures 22% of European Market, 5 Fold Growth in 4 Years 송영두 2025.05.28 오전 10:01 Trump Eyes Drug Tariffs-What It Means for K-Bio 김진수 2025.05.07 오전 10:16 Bio&Pharma Stocks: BL Pharmtech, Celltrion and Amicogen on the Rise 임정요 2025.02.27 오전 08:33 Celltrion's Remsima becomes S.Korea's first 'blockbuster' drug 임정요 2025.02.27 오전 08:36 Celltrion, Track to Achieve 5 Trillion won in Annual Revenue This Year with Successful U.S. Expan... 신민준 2025.03.06 오전 10:10 로딩중..
Remsima
Remsima
